BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28418115)

  • 21. HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes.
    Cerna M; Novota P; Kolostova K; Cejkova P; Zdarsky E; Novakova D; Kucera P; Novak J; Andel M
    Eur J Immunogenet; 2003 Dec; 30(6):401-7. PubMed ID: 14675393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New-onset insulin-dependent diabetes due to nivolumab.
    Zaied AA; Akturk HK; Joseph RW; Lee AS
    Endocrinol Diabetes Metab Case Rep; 2018; 2018():. PubMed ID: 29623210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of type 1 diabetes development in children with incidental hyperglycemia: A multicenter Italian study.
    Lorini R; Alibrandi A; Vitali L; Klersy C; Martinetti M; Betterle C; d'Annunzio G; Bonifacio E;
    Diabetes Care; 2001 Jul; 24(7):1210-6. PubMed ID: 11423504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and HLA genotype analysis of immune checkpoint inhibitor-associated diabetes mellitus: a single-center case series from China.
    Liu YC; Liu H; Zhao SL; Chen K; Jin P
    Front Immunol; 2023; 14():1164120. PubMed ID: 37359544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group.
    Horton V; Stratton I; Bottazzo GF; Shattock M; Mackay I; Zimmet P; Manley S; Holman R; Turner R
    Diabetologia; 1999 May; 42(5):608-16. PubMed ID: 10333055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pembrolizumab-induced fulminant type 1 diabetes with C-peptide persistence at first referral.
    Kusuki K; Suzuki S; Mizuno Y
    Endocrinol Diabetes Metab Case Rep; 2020 Apr; 2020():. PubMed ID: 32478673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nivolumab-induced type 1 diabetes mellitus as an immune-related adverse event.
    Yilmaz M
    J Oncol Pharm Pract; 2020 Jan; 26(1):236-239. PubMed ID: 30955467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype.
    Petrone A; Galgani A; Spoletini M; Alemanno I; Di Cola S; Bassotti G; Picardi A; Manfrini S; Osborn J; Pozzilli P; Buzzetti R
    Diabetes Metab Res Rev; 2005; 21(3):271-5. PubMed ID: 15786423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Childhood Diabetes in Finland (DiMe) Study Group.
    Veijola R; Vähäsalo P; Tuomilehto-Wolf E; Reijonen H; Kulmala P; Ilonen J; Akerblom HK; Knip M
    Diabetes; 1995 Sep; 44(9):1021-8. PubMed ID: 7657023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade.
    Correale P; Saladino RE; Giannarelli D; Giannicola R; Agostino R; Staropoli N; Strangio A; Del Giudice T; Nardone V; Altomonte M; Pastina P; Tini P; Falzea AC; Imbesi N; Arcati V; Romeo G; Caracciolo D; Luce A; Caraglia M; Giordano A; Pirtoli L; Necas A; Amler E; Barbieri V; Tassone P; Tagliaferri P
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32554614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Triad of markers for identifying children at high risk of developing insulin-dependent diabetes mellitus.
    Ginsberg-Fellner F; Witt ME; Franklin BH; Yagihashi S; Toguchi Y; Dobersen MJ; Rubinstein P; Notkins AL
    JAMA; 1985 Sep; 254(11):1469-72. PubMed ID: 3897593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-thyroid peroxidase antibody, IA-2 antibody, and fasting C-peptide levels predict beta cell failure in patients with latent autoimmune diabetes in adults (LADA)--a 5-year follow-up of the Ehime study.
    Murao S; Kondo S; Ohashi J; Fujii Y; Shimizu I; Fujiyama M; Ohno K; Takada Y; Nakai K; Yamane Y; Osawa H; Makino H
    Diabetes Res Clin Pract; 2008 Apr; 80(1):114-21. PubMed ID: 18342387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA DRB1, DQB1 and insulin promoter VNTR polymorphisms: interactions and the association with adult-onset diabetes mellitus in Czech patients.
    Cejkova P; Novota P; Cerna M; Kolostova K; Novakova D; Kucera P; Novak J; Andel M; Weber P; Zdarsky E
    Int J Immunogenet; 2008 Apr; 35(2):133-40. PubMed ID: 18279373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated Adrenocorticotropin Deficiency due to Nivolumab-induced Hypophysitis in a Patient with Advanced Lung Adenocarcinoma: A Case Report and Literature Review.
    Ohara N; Ohashi K; Fujisaki T; Oda C; Ikeda Y; Yoneoka Y; Hashimoto T; Hasegawa G; Suzuki K; Takada T
    Intern Med; 2018 Feb; 57(4):527-535. PubMed ID: 29151505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nivolumab-induced acute-onset type 1 diabetes mellitus as an immune-related adverse event: A case report.
    Hatakeyama Y; Ohnishi H; Suda K; Okamura K; Shimada T; Yoshimura S
    J Oncol Pharm Pract; 2019 Dec; 25(8):2023-2026. PubMed ID: 30526346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset.
    Kawabata Y; Ikegami H; Awata T; Imagawa A; Maruyama T; Kawasaki E; Tanaka S; Shimada A; Osawa H; Kobayashi T; Hanafusa T; Tokunaga K; Makino H;
    Diabetologia; 2009 Dec; 52(12):2513-21. PubMed ID: 19812988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
    Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
    Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical, autoimmune, and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan (Ehime Study).
    Takeda H; Kawasaki E; Shimizu I; Konoue E; Fujiyama M; Murao S; Tanaka K; Mori K; Tarumi Y; Seto I; Fujii Y; Kato K; Kondo S; Takada Y; Kitsuki N; Kaino Y; Kida K; Hashimoto N; Yamane Y; Yamawaki T; Onuma H; Nishimiya T; Osawa H; Saito Y; Makino H;
    Diabetes Care; 2002 Jun; 25(6):995-1001. PubMed ID: 12032105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.
    Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history of Type 1 diabetes affects insulin secretion in patients with 'Type 2' diabetes.
    Lundgren VM; Andersen MK; Isomaa B; Tuomi T
    Diabet Med; 2013 May; 30(5):e163-9. PubMed ID: 23157220
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.